Population genetic structure and polymorphism analysis of gene encoding apical membrane antigen-1 (AMA-1) of Iranian Plasmodium vivax wild isolates

Acta Tropica

Volumn 126, Issue 3, 2013, Pages 269-279

  Zakeri, Sedigheh ^a   Sadeghi, Hengameh ^b   Mehrizi, Akram Abouie ^a   Djadid, Navid Dinparast ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b URMIA UNIVERSITY   (Iran)

Author keywords

Apical membrane antigen 1 (AMA 1); Genetic polymorphism; Iran; Plasmodium vivax; Population structure

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; GENOMIC DNA;

ANTIGEN; DETECTION METHOD; GENETIC DIFFERENTIATION; GENETIC STRUCTURE; MALARIA; MEMBRANE; PATHOGEN; POLYMORPHISM; POPULATION GENETICS; VACCINE;

ADULT; AGED; APICAL MEMBRANE ANTIGEN 1 GENE; ARTICLE; BALANCING SELECTION; BLOOD SAMPLING; CHILD; DNA ISOLATION; EPITOPE MAPPING; ETHNIC GROUP; FEMALE; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IRANIAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PLASMODIUM VIVAX; POINT MUTATION; POPULATION GENETIC STRUCTURE; PRESCHOOL CHILD; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNINDEXED SEQUENCE;

ADOLESCENT; ADULT; AGED; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; DNA, PROTOZOAN; EPITOPES; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; INFANT; IRAN; MALARIA, VIVAX; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

IRAN;

PLASMODIUM VIVAX;

EID: 84875930312     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2013.02.017     Document Type: Article

References (80)

1. Anders R.F., Crewther P.E., Edwards S., Margetts M., Matthew M.L., Pollock B., Pye D. Immunization with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 1998, 16:240-247.
2. Anstey N.M., Russell B., Yeo T.W., Price R.N. The pathophysiology of vivax malaria. Trends Parasitol. 2009, 25:220-227.
3. Arévalo-Herrera M., Chitnis C., Herrera S. Current status of Plasmodium vivax vaccine. Hum. Vaccin. 2010, 6:124-132.
4. Arias A.E., Corredor A. Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy. Trop. Med. Parasitol. 1989, 40:21-23.
5. Baird J.K. Chloroquine resistance in Plasmodium vivax. Antimicrob. Agents Chemother. 2004, 48:4075-4083.
6. Balloux F., Lugon-Moulin N. The estimation of population differentiation with microsatellite markers. Mol. Ecol. 2002, 11:155-165.
7. Bannister L.H., Hopkins J.M., Dluzewski A.R., Margos G., Williams I.T., Blackman M.J., Kocken C.H., Thomas A.W., Mitchell G.H. Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite development. J. Cell Sci. 2003, 116:3825-3834.
8. Bueno L.L., Lobo F.P., Morais C.G., Mourão L.C., de ávila R.A., Soares I.S., Fontes C.J., Lacerda M.V., Chavez Olórtegui C., Bartholomeu D.C., Fujiwara R.T., Braga E.M. Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1). PLoS One 2011, 6:e21289.
9. Cheng Q., Saul A. Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax. Mol. Biochem. Parasitol. 1994, 65:183-187.
10. Chesne-Seck M.L., Pizarro J.C., Vulliez-Le Normand B., Collins C.R., Blackman M.J., Faber B.W., Remarque E.J., Kocken C.H., Thomas A.W., Bentley G.A. Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites. Mol. Biochem. Parasitol. 2005, 144:55-67.
11. Chung J.Y., Chun E.H., Chun J.H., Kho W.G. Analysis of the Plasmodium vivax apical membrane antigen-1 gene from re-emerging Korean isolates. Parasitol. Res. 2003, 90:325-329.
12. Cortés A., Mellombo M., Mueller I., Benet A., Reeder J.C., Anders R.F. Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA-1. Infect. Immun. 2003, 71:1416-1426.
13. Crompton P.D., Pierce S.K., Miller L.H. Advances and challenges in malaria vaccine development. J. Clin. Invest. 2010, 120:4168-4178.
14. Cui L., Escalante A.A., Imwong M., Snounou G. The genetic diversity of Plasmodium vivax populations. Trends Parasitol. 2003, 19:220-226.
15. de Souza-Neiras W.C., de Melo L.M., Machado R.L. The genetic diversity of Plasmodium vivax - a review. Mem. Inst. Oswaldo Cruz 2007, 102:245-254.
16. Deans J.A., Alderson T., Thomas A.W., Mitchell G.H., Lennox E.S., Cohen S. Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin. Exp. Immunol. 1982, 49:297-309.
17. Dias S., Somarathna M., Manamperi A., Escalante A.A., Gunasekera A.M., Udagama P.V. Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1) and the ensuing strainspecific immune responses in patients from Sri Lanka. Vaccine 2011, 29:7491-7504.
18. Dunker A.K., Brown C.J., Lawson J.D., Iakoucheva L.M., Obradovic Z. Intrinsic disorder and protein function. Biochemistry 2002, 41:6573-6582.
19. Dutta S., Malhotra P., Chauhan V.S. Sequence analysis of apical membrane antigen 1 (AMA-1) of Plasmodium cynomolgi bastianelli. Mol. Biochem. Parasitol. 1995, 73:267-270.
20. Dutta S., Haynes J.D., Moch J.K., Barbosa A., Lanar D.E. Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:12295-12300.
21. Egea R., Casillas S., Barbadilla A. Standard and generalized McDonald-Kreitman test: a website to detect selection by comparing different classes of DNA sites. Nucleic Acid. Res. 2008, 36:W157-W162.
22. Figtree M., Pasay C.J., Slade R., Cheng Q., Cloonan N., Walker J., Saul A. Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA-1 and MSP-1 genes. Mol. Biochem. Parasitol. 2000, 108:53-66.
23. Fu Y.X., Li W.H. Statistical tests of neutrality of mutations. Genetics 1993, 133:693-709.
24. Galinski M.R., Barnwell J.W. Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development. Parasitol. Today 1996, 12:20-29.
25. Garg S., Alam M.T., Das M.K., Dev V., Kumar A., Dash A.P., Sharma Y.D. Sequence diversity and natural selection at domain I of the apical membrane antigen 1 among Indian Plasmodium falciparum populations. Malar. J. 2007, 6:154.
26. Grynberg P., Fontes C.J., Hughes A.L., Braga E.M. Polymorphism at the apical membrane antigen 1 locus reflects the world population history of Plasmodium vivax. BMC Evol. Biol. 2008, 8:123.
27. Guerra C.A., Snow R.W., Hay S.I. Mapping the global extent of malaria in 2005. Trends Parasitol. 2006, 22:353-358.
28. Gunasekera A.M., Wickramarachchi T., Neafsey D.E., Ganguli I., Perera L., Premaratne P.H., Hartl D., Handunnetti S.M., Udagama-Randeniya P.V., Wirth D.F. Genetic diversity and selection at the Plasmodium vivax apical membrane antigen-1 (PvAMA-1) locus in a Sri Lankan population. Mol. Biol. Evol. 2007, 24:939-947.
29. Han E.T., Park J.H., Shin E.H., Choi M.H., Oh M.D., Chai J.Y. Apical membrane antigen-1 (AMA-1) gene sequences of re-emerging Plasmodium vivax in South Korea. Korean J. Parasitol. 2002, 40:157-162.
30. Hay S.I., Guerra C.A., Tatem A.J., Noor A.M., Snow R.W. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect. Dis. 2004, 4:327-336.
31. Hehl A.B., Lekutis C., Grigg M.E., Bradley P.J., Dubremetz J.F., Ortega-Barria E., Boothroyd J.C. Toxoplasma gondii homologue of Plasmodium apical membrane antigen 1 is involved in invasion of host cells. Infect. Immun. 2000, 68:7078-7086.
32. Hodder A.N., Crewther P.E., Matthew M.L., Reid G.E., Moritz R.L., Simpson R.J., Anders R.F. The disulfide bond structure of Plasmodium apical membrane antigen-1. J. Biol. Chem. 1996, 271:29446-29452.
33. Holder A.A. Preventing merozoite invasion of erythrocytes. Malaria Vaccine Development: A Multi-Immune Approach 1994, 77-104. American Society for Microbiology Press, Washington, DC. S.L. Hoffman (Ed.).
34. Howell S.A., Withers-Martinez C., Kocken C.H., Thomas A.W., Blackman M.J. Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J. Biol. Chem. 2001, 276:31311-31320.
35. Howell S.A., Well I., Fleck S.L., Kettleborough C., Collins C.R., Blackman M.J. A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxta membrane cleavage. J. Biol. Chem. 2003, 278:23890-23898.
36. Kocken C.H., Withers-Martinez C., Dubbeld M.A., van der Wel A., Hackett F., Valderrama A., Blackman M.J., Thomas A.W. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect. Immun. 2002, 70:4471-4476.
37. Li F., Dluzewski A., Coley A.M., Thomas A., Tilley L., Anders R.F., Foley M. Phage-displayed peptides bind to the malarial protein apical membrane antigen-1 and inhibit the merozoite invasion of host erythrocytes. J. Biol. Chem. 2002, 277:50303-50310.
38. Librado P., Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 2009, 25:1451-1452.
39. List C., Qi W., Maag E., Gottstein B., Müller N., Felger I. Serodiagnosis of Echinococcus spp. infection: explorative selection of diagnostic antigens by peptide microarray. PLoS Negl. Trop. Dis. 2010, 4:e771.
40. Marshall V.M., Peterson M.G., Lew A.M., Kemp D.J. Structure of the apical membrane antigen I (AMA-1) of Plasmodium chabaudi. Mol. Biochem. Parasitol. 1989, 37:281-283.
41. McDonald J.H., Kreitman M. Adaptive protein evolution at the Adh locus in Drosophila. Nature 1991, 351:652-654.
42. Mendis K., Sina B.J., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2001, 64:97-106.
43. Mitchell G.H., Thomas A.W., Margos G., Dluzewski A.R., Bannister L.H. Apical membrane antigen1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. Infect. Immun. J. 2004, 72:154-158.
44. Moon S.U., Na B.K., Kang J.M., Kim J.Y., Cho S.H., Park Y.K., Sohn W.M., Lin K., Kim T.S. Genetic polymorphism and effect of natural selection at domain I of apical membrane antigen-1 (AMA-1) in Plasmodium vivax isolates from Myanmar. Acta Trop. 2010, 114:71-75.
45. Múfalo B.C., Gentil F., Bargieri D.Y., Costa F.T., Rodrigues M.M., Soares I.S. Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection. Microbes. Infect. 2008, 10:1266-1273.
46. Narum D.L., Thomas A.W. Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 1994, 67:59-68.
47. Ord R.L., Tami A., Sutherland C.J. ama1 genes of sympatric Plasmodium vivax and P. falciparum from venezuela differ significantly in genetic diversity and recombination frequency. PLoS One 2008, 3:e3366. 10.1371/journal.pone.0003366.
48. Peterson M.G., Marshall V.M., Smythe J.A., Crewther P.E., Lew A., Silva A., Anders R.F., Kemp D.J. Integral membrane protein located in the apical complex of Plasmodium falciparum. Mol. Cell. Biol. 1989, 7:3151-3154.
49. Pizarro J.C., Vulliez-Le Normand B., Chesne-Seck M.L., Collins C.R., Withers-Martinez C., Hackett F., Blackman M.J., Faber B.W., Remarque E.J., Kocken C.H., Thomas A.W., Bentley G.A. Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science 2005, 308:408-411.
50. Polley S.D., Mwangi T., Kocken C.H., Thomas A.W., Dutta S., Lanar D.E., Remarque E., Ross A., Williams T.N., Mwambingu G., Lowe B., Conway D.J., Marsh K. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen1 (AMA1) and their associations with protection from malaria. Vaccine 2004, 23:718-728.
51. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., Anstey N.M. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 2007, 77:79-87.
52. Price R.N., Douglas N.M., Anstey N.M. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr. Opin. Infect. Dis. 2009, 22:430-435.
53. Putaporntip C., Jongwutiwes S., Grynberg P., Cui L., Hughes A.L. Nucleotide sequence polymorphism at the apical membrane antigen-1 locus reveals population history of Plasmodium vivax in Thailand. Infect. Genet. Evol. 2009, 9:1295-1300.
54. Rajesh V., Elamaran M., Vidya S., Gowrishankar M., Kochar D., Das A. Plasmodium vivax: genetic diversity of the apical membrane antigen-1 (AMA-1) in isolates from India. Exp. Parasitol. 2007, 116:252-256.
55. Remarque E.J., Faber B.W., Kocken C.H., Thomas A.W. Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol. 2008, 24:74-84.
56. Richie T.L., Saul A. Progress and challenges for malaria vaccines. Nature 2002, 415:694-701.
57. Riley E.M., Wagner G.E., Ofori M.F., Wheeler J.G., Akanmori B.D., Tetteh K., McGuinness D., Bennett S., Nkrumah F.K., Anders R.F., Koram K.A. Lack of association between maternal antibody and protection of African infants from malaria infection. Infect. Immun. 2000, 68:5856-5863.
58. Rodrigues M.H., Rodrigues K.M., Oliveira T.R., Comodo A.N., Rodrigues M.M., Kocken C.H., Thomas A.W., Soares I.S. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Int J Parasitol. 2005, 35:185-192.
59. Rogerson S.J., Carter R. Severe vivax malaria: newly recognised or rediscovered. PLoS Med. 2008, 5:e136.
60. Rozas J., SanchezDelBarrio J.C., Messeguer X., Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 2003, 19:2496-2497.
61. Saha S., Raghava G.P.S. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 2006, 65:40-48.
62. Sharma S., Pathak S. Malaria vaccine: a current perspective. J. Vector. Borne. Dis. 2008, 45:1-20.
63. Silvie O., Franetich J.F., Charrin S., Mueller M.S., Siau A., Bodescot M., Rubinstein E., Hannoun L., Charoenvit Y., Kocken C.H., Thomas A.W., Van Gemert G.J., Sauerwein R.W., Blackman M.J., Anders R.F., Pluschke G., Mazier D. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J. Biol. Chem. 2004, 279:9490-9496.
64. Snounou G., Viriyakosol S., Zhu X.P., Jarra W., Pinheiro L., do Rosario V.E., Thaithong S., Brown K.N. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 1993, 61:315-320.
65. Stowers A.W., Kennedy M.C., Keegan B.P., Saul A., Long C.A., Miller L.H. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1confers protection against blood-stage malaria. Infect. Immun. 2002, 12:6961-6967.
66. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989, 123:585-595.
67. Tan L.K., Yacoub S., Scott S., Bhagani S., Jacobs M. Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect. Dis. 2008, 8:449-454.
68. Targett G.A., Greenwood B.M. Malaria vaccines and their potential role in the elimination of malaria. Malar. J. 2008, 1:S10.
69. Tediosi F., Maire N., Penny M., Studer A., Smith T.A. Simulation of the cost-effectiveness of malaria vaccines. Malar. J. 2009, 8:127.
70. Thakur A., Alam M.T., Bora H., Kaur P., Sharma Y.D. Plasmodium vivax: sequence polymorphism and effect of natural selection at apical membrane antigen 1 (PvAMA1) among Indian population. Gene 2008, 419:35-42.
71. Thomas A.W., Deans J.A., Mitchell G.H., Alderson T., Cohen S. The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes. Mol. Biochem. Parasitol. 1984, 13:187-199.
72. Thomas A.W., Trape J.F., Rogier C., Goncalves A., Rosario V.E., Narum D.L. High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1. Am. J. Trop. Med. Hyg. 1994, 51:730-740.
73. Tjitra E., Anstey N.M., Sugiarto P., Warikar N., Kenangalem E., Karyana M., Lampah D.A., Price R.N. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008, 5:e128.
74. Triglia T., Healer J., Caruana S.R., Hodder A.N., Anders R.F., Crabb B.S., Cowman A.F. Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. Mol. Microbiol. 2000, 38:706-718.
75. Udhayakumar V., Kariuki S., Kolczack M., Girma M., Roberts J.M., Oloo A.J., Nahlen B.L., Lal A.A. Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. Am. J. Trop. Med. Hyg. 2001, 65:100-107.
76. Waters A.P., Thomas A.W., Deans J.A., Mitchell G.H., Hudson D.E., Miller L.H., McCutchan T.F., Cohen S. A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium. J. Biol. Chem. 1990, 265:17974-17979.
77. Yang Z.R., Thomson R., McNeil P., Esnouf R.M. RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 2005, 21:3369-3376.
78. Zakeri S., Mehrizi A.A., Djadid N.D., Snounou G. Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran. Trop. Med. Int. Health 2006, 11:729-737.
79. Zakeri S., Mehrizi A.A., Noorizadeh S., Djadid N.D., Snounou G. Population structure analysis of Iranian Plasmodium vivax in areas with different malaria endemicity. Am. J. Trop. Med. Hyg. 2006, 74:394-400.
80. Zakeri S., Barjesteh H., Djadid N.D. Merozoite surface protein-3a is a reliable marker for population genetic analysis of Plasmodium vivax. Malar. J. 2006, 3(5):53.